Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ono Pharmaceutical (OPHLY)

Ono Pharmaceutical (OPHLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ono Pharmaceutical

Description:

ONO Pharmaceutical Co., Ltd., was incorporated in Japan on July 4, 1947. The Company along with its subsidiaries is engaged in research & development, manufacturing and selling of medical and general pharmaceutical products. Its product portfolio includes GLACTIV Tablets for the Treatment of Type 2 Diabetes; RECALBON Tablets for the Treatment of Osteoporosis; EMEND Capsules / PROEMEND for Intravenous Injection for the Treatment of Chemotherapy-induced Nausea and Vomiting, STAYBLA Tablets for the Treatment of Overactive Bladder; RIVASTACH Patch for the Treatment of Alzheimer's Disease; ORENCIA for Subcutaneous Injection for the Treatment of Rheumatoid Arthritis; FORXIGA Tablets for the Treatment of Type 2 Diabetes; OPALMON Tablets for the Treatment of Peripheral Circulatory Disorder; ONOACT for Intravenous Infusion for the Treatment of Tachyarrhythmia Intra-operative or Post-operative, or Tachyarrhythmia in Left Ventricular Dysfunction; and ELASPOL for Injection for the Treatment of Acute Lung Injury Associated with Systemic Inflammatory Response Syndrome. The Company has operations in geographical areas including; Japan, Europe, and Asia.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K
Short Volume Ratio 0.37

Growth:

1-Year Return -28.53%
3-Year Return -36.80%
5-Year Return -16.35%

Per-Share Information:

Latest Earnings Date N/A
Next Ex-Dividends Date 09/25/14
Dividend Payable Date 12/16/14
Dividend Payout Ratio 0.00%

OPHLY Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 405.02
Price/Book 2.91
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar